BMRN: BioMarin Pharmaceutical Inc. Stock

by  •  • Comments Off on BMRN: BioMarin Pharmaceutical Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 12,138.04
Enterprise Value ($M) 11,790.33
Book Value ($M) 5,657.99
Book Value / Share 29.51
Price / Book 2.15
NCAV ($M) 1,901.48
NCAV / Share 9.92
Price / NCAV 6.38

Profitability (mra)
Return on Invested Capital (ROIC) 0.07
Return on Assets (ROA) 0.06
Return on Equity (ROE) 0.08

Liquidity (mrq)
Quick Ratio 3.29
Current Ratio 5.33

Balance Sheet (mrq) ($M)
Current Assets 3,232.43
Assets 6,988.94
Liabilities 1,330.95
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,853.91
Operating Income 570.21
Net Income 426.86
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 572.84
Cash from Investing 136.49
Cash from Financing -526.45

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
14 hours ago 13G/A BlackRock, Inc. 10.80 -9.48
02-13 13G/A Capital Research Global Investors 6.80 20.58
09-30 13G Viking Global Investors Lp 5.10
07-10 13G/A Vanguard Group Inc 10.00 5.23

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-28 127,460 995,469 12.80
2025-04-25 102,763 564,978 18.19
2025-04-24 121,268 765,316 15.85
2025-04-23 275,391 985,343 27.95

(click for more detail)

Similar Companies
BIIB – Biogen Inc. BLUE – bluebird bio, Inc.
BMEA – Biomea Fusion, Inc. BPMC – Blueprint Medicines Corporation
CABA – Cabaletta Bio, Inc.


Financial data and stock pages provided by
Fintel.io